Literature DB >> 26201917

Small hepatocellular carcinoma: current and future approaches.

Wen-Ming Cong1, Meng-Chao Wu2.   

Abstract

Over 3 decades have passed since the first report of small hepatocellular carcinoma (SHCC), which has been confirmed as one of the most significant prognostic factors. Obviously, it is indeed very important to know when an early SHCC will become more aggressive and lead to worse clinical outcome once it grows beyond a critical size. However, so far, no consensus has been achieved on the size criterion for SHCC among different authors or different clinical practice guidelines that have been used worldwide, although there are currently numerous cutoff values for tumor size used to define SHCC, including 5, 3 and 2 cm in diameter, etc. Herein, based on our current understanding concerning the pathobiological features of SHCC, we briefly review the history of SHCC study, analyze the advantages and limitations of the above criteria for SHCC, and discuss the pathobiological characteristics as well as the clinical significance of SHCC.

Entities:  

Keywords:  Early hepatocellular carcinoma; Guidelines; Pathobiological features; Small hepatocellular carcinoma; Surgical outcome

Year:  2013        PMID: 26201917     DOI: 10.1007/s12072-013-9454-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  78 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

Review 2.  Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.

Authors:  Masamichi Kojiro
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

3.  Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.

Authors:  Toyoki Moribe; Norio Iizuka; Toshiaki Miura; Naoki Kimura; Shigeru Tamatsukuri; Hideo Ishitsuka; Yoshihiko Hamamoto; Kazuhiko Sakamoto; Takao Tamesa; Masaaki Oka
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

4.  Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.

Authors:  Eiji Ando; Ryoko Kuromatsu; Masatoshi Tanaka; Akio Takada; Nobuyoshi Fukushima; Shuji Sumie; Sakae Nagaoka; Jyunji Akiyoshi; Kinya Inoue; Takuji Torimura; Ryukichi Kumashiro; Takato Ueno; Michio Sata
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

5.  Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm.

Authors:  Yo-ichi Yamashita; Eiji Tsuijita; Kazuki Takeishi; Megumu Fujiwara; Shinsuke Kira; Masaki Mori; Shinichi Aishima; Akinobu Taketomi; Ken Shirabe; Terutoshi Ishida; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2011-12-28       Impact factor: 5.344

6.  Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.

Authors:  Xin-Yuan Lu; Tao Xi; Wan-Yee Lau; Hui Dong; Zhen Zhu; Feng Shen; Meng-Chao Wu; Wen-Ming Cong
Journal:  Ann Surg Oncol       Date:  2011-02-10       Impact factor: 5.344

Review 7.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

8.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Validation of the modified TNM-Izumi classification for hepatocellular carcinoma.

Authors:  C Staudacher; A Chiappa; F Biella; R A Audisio; E Bertani; A P Zbar
Journal:  Tumori       Date:  2000 Jan-Feb

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  6 in total

Review 1.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.

Authors:  Wen-Ming Cong; Hong Bu; Jie Chen; Hui Dong; Yu-Yao Zhu; Long-Hai Feng; Jun Chen
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

2.  Reclassification of tumor size for solitary HBV-related hepatocellular carcinoma by minimum p value method: a large retrospective study.

Authors:  Hongzhi Liu; Yuan Yang; Chuanchun Chen; Lei Wang; Qizhen Huang; Jianxing Zeng; Kongying Lin; Yongyi Zeng; Pengfei Guo; Weiping Zhou; Jingfeng Liu
Journal:  World J Surg Oncol       Date:  2020-07-24       Impact factor: 2.754

3.  Association between Ambient Particulate Matter 2.5 Exposure and Mortality in Patients with Hepatocellular Carcinoma.

Authors:  Chern-Horng Lee; Sen-Yung Hsieh; Wen-Hung Huang; I-Kuan Wang; Tzung-Hai Yen
Journal:  Int J Environ Res Public Health       Date:  2019-07-12       Impact factor: 3.390

4.  Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy.

Authors:  Yifan Han; Jianxiang Liu; Jiali Pan; Hongyu Chen; Ning Tan; Qian Kang; Yuqing Yang; Xiaoyuan Xu; Wengang Li
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

5.  An excellent nomogram predicts microvascular invasion that cannot independently stratify outcomes of small hepatocellular carcinoma.

Authors:  Huanhuan Chong; Peiyun Zhou; Chun Yang; Mengsu Zeng
Journal:  Ann Transl Med       Date:  2021-05

6.  Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas.

Authors:  Yanyan Wei; Feng Dai; Yongxiang Yi; Wei Ye; Wei Zhao
Journal:  Oncol Lett       Date:  2018-08-03       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.